CAT
Caterpillar Inc.
CAT has a slight edge over TTEK overall, supported by stronger modeled upside and lower modeled downside.
TTEK
Tetra Tech, Inc.
TTEK offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
TTEK Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Healthy | |
| Healthy |
TTEK's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
TTEK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 23x | $39.43 | — |
| Forward | 23x | $39.43 | — |
| Cheap | 26x | $44.30 | +12% |
| Fair | 33x | $55.11 | +40% |
| Expensive | 42x | $71.58 | +82% |
Historical ranges are pointers, not guarantees.
TTEK has the edge over CAT in the historical PE scenario, which offers more potential upside but is not a forecast.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
CAT has the edge over TTEK on the outlook, with more favorable valuation expectations.
TTEK Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for TTEK, with profitability improving.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT earned $25.48 per share over the past year, up 31% from the year before.
TTEK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.71 | +1.3% |
| Q3 2026 | $1.69 | +82% |
TTEK has the edge over CAT in the latest year-over-year earnings comparison.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over TTEK on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over TTEK on profitability, with a higher operating margin.
TTEK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.3B | +0.5% |
| Q2 2026 | $1.3B | -4.5% |
| Q1 2026 | $1.2B | -7.7% |
| Q4 2025 | $1.2B | -15% |
TTEK's revenue is down over the past year, though its latest quarter was up: $1.3B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 12% | 0 points |
| Q1 2026 | 11% | +7.8 points |
| Q4 2025 | 12% | +10 points |
| Q3 2025 | 14% | N/A |
| Q2 2025 | 12% | N/A |
| Q1 2025 | 3% | N/A |
| Q4 2024 | 1.6% | N/A |
TTEK's operating margin was 12% last quarter, about level with the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the edge over TTEK in the latest year-over-year cash flow comparison.
TTEK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $225.1M | -35% |
| Q1 2026 | $159.4M | +$171.1M |
| Q4 2025 | $68.1M | +607% |
CAT has the edge over TTEK in the latest year-over-year cash flow comparison.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over TTEK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
TTEK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2.1M shares |
| 1 year | -1.9% | -5.1M shares |
TTEK has 260M diluted shares, down 1.9% from a year ago, with $252M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q2 2026 | $100M |
| Q1 2026 | $52M |
| Q4 2025 | $50M |
| Q3 2025 | $50M |
| Q2 2025 | $25M |
| Q1 2025 | $150M |
| Q4 2024 | $25M |
TTEK spent $252M buying back its own shares over the past year.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has the edge over TTEK on leverage, with a lower net debt burden relative to earnings.
TTEK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.9x | Very low |
| Q1 2026 | 1.0x | Very low |
| Q4 2025 | 1.0x | Very low |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | 2.1x | Moderate |
| Q4 2024 | 1.3x | Healthy |
TTEK's net debt is less than a year of its operating earnings (EBITDA), down from 1.4 years a year ago.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
TTEK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.3 | Neutral |
| Stochastic | 86.5 | Overbought |
TTEK's weekly RSI is 65 (neutral) and its Stochastic is 87 (overbought).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
TTEK PE vs Industrials Sector
| Metric | TTEK | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 24x | 3.1% below |
| PE % | 9 | 58 | 49 pts below |
TTEK has the edge over CAT on valuation relative to its sector.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
TTEK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.3 | 8.6% above |
| 20 week MA | $35.1 | 12% above |
| 50 week MA | $33.6 | 17% above |
| 100 week MA | $34.1 | 16% above |
| 200 week MA | $35.1 | 12% above |
TTEK has the edge over CAT on trend strength, trading above more of its moving averages.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has finished every year since 2020 higher, and it's up 3.8% so far in 2026.
TTEK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.3 | $23.1 | +34% |
| 2021 | $23.1 | $33.6 | +45% |
| 2022 | $33.6 | $29.8 | -11% |
| 2023 | $29.8 | $33.4 | +12% |
| 2024 | $33.4 | $39.8 | +19% |
| 2025 | $39.8 | $34.0 | -15% |
| 2026 YTD | $34.0 | $39.4 | +16% |
TTEK has the edge over CAT on returns for 2026, with the stronger performance.